Disc. on Uterine Leiomyoma (Uterine Fibroids) - Market Research Reports

NAVI MUMBAI, India - Aug. 8, 2014 - PRLog -- Bharat Book Bureau presents the new report, on "Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2014". The report is built using data and information sourced from it’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by it’s team.

Summary

‘Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2014’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids)’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for  Uterine Leiomyoma (Uterine Fibroids) (https://www.bharatbook.com/healthcare-market-research-reports-417826/uterine-leiomyoma-fibroids-pipeline-1.html), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Uterine Leiomyoma (Uterine Fibroids) and special features on late-stage and discontinued projects.

It’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from it’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by it’s team. Drug profiles/records featured in the report undergoes periodic updating following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope

- The report provides a snapshot of the global therapeutic landscape of Uterine Leiomyoma (Uterine Fibroids)
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Uterine Leiomyoma (Uterine Fibroids) and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Uterine Leiomyoma (Uterine Fibroids) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Uterine Leiomyoma (Uterine Fibroids)
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Uterine Leiomyoma (Uterine Fibroids) pipeline depth and focus of Indication therapeutics

Table of  Contents

1. Introduction
2. Global Markets Direct Report Coverage
3. Uterine Leiomyoma (Uterine Fibroids) Overview
4. Therapeutics Development
5. Pipeline Products for Uterine Leiomyoma (Uterine Fibroids) - Overview
6. Pipeline Products for Uterine Leiomyoma (Uterine Fibroids) - Comparative Analysis
7.Late Stage Products
8. Clinical Stage Products
9. Early Stage Products
10.Uterine Leiomyoma (Uterine Fibroids) - Products under Development by Companies

List of Tables

Number of Products under Development for Uterine Leiomyoma (Uterine Fibroids), H2 2014 9
Number of Products under Development for Uterine Leiomyoma (Uterine Fibroids) - Comparative Analysis, H2 2014 10
Number of Products under Development by Companies, H2 2014 12
Number of Products under Investigation by Universities/Institutes, H2 2014 13
Comparative Analysis by Late Stage Development, H2 2014 14

For more information kindly visit :https://www.bharatbook.com/healthcare-market-research-reports-417826/uterine-leiomyoma-fibroids-pipeline-1.html

Discounted Reports :  https://www.bharatbook.com/discounted-reports.asp

Related Reports :https://www.bharatbook.com/market-research-report/life-sciences.html?SCatID=4

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry analysis , country reports , business reports, newsletters and online databases  Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

OR

Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:  https://twitter.com/researchbook
Our Blog : http://blog.bharatbook.com/